162 related articles for article (PubMed ID: 31825155)
1. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy.
Hakim MS; Rahmadika N; Jariah ROA
Rev Med Virol; 2020 Mar; 30(2):e2094. PubMed ID: 31825155
[TBL] [Abstract][Full Text] [Related]
2. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8
Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B
Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771
[TBL] [Abstract][Full Text] [Related]
3. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
Cheruvu S; Marks K; Talal AH
Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
[TBL] [Abstract][Full Text] [Related]
4. T cell responses during HBV and HCV infections: similar but not quite the same?
Shoukry NH; Walker CM
Curr Opin Virol; 2021 Dec; 51():80-86. PubMed ID: 34619514
[TBL] [Abstract][Full Text] [Related]
5. Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis.
Brunetto MR; Colombatto P; Bonino F
World J Gastroenterol; 2009 Feb; 15(5):531-7. PubMed ID: 19195054
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies.
Mustafayev K; Torres H
Clin Microbiol Infect; 2022 Oct; 28(10):1321-1327. PubMed ID: 35283317
[TBL] [Abstract][Full Text] [Related]
7. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
[TBL] [Abstract][Full Text] [Related]
8. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
10. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Potthoff A; Berg T; Wedemeyer H;
Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Gene Therapy Coming to Age.
Soriano V
AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
[TBL] [Abstract][Full Text] [Related]
12. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome.
Delaney WE
Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
Juan J; Feld JJ
Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
[TBL] [Abstract][Full Text] [Related]
15. Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives.
Wieland D; Hofmann M; Thimme R
Dig Dis; 2017; 35(4):334-338. PubMed ID: 28468011
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection.
Masgala A; Bonovas S; Nikolopoulos GK
Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578
[TBL] [Abstract][Full Text] [Related]
17. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
Singh R; Kaul R; Kaul A; Khan K
World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
Liu CJ
J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
[TBL] [Abstract][Full Text] [Related]
20. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]